Traded Jul 8 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Jul 1, 2026 · Filed Jul 2, 2026
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
grant award
Code A — grant or award
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded Jul 8 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Helen Torley (PRESIDENT AND CEO) sold ~$70K of Halozyme
Scheduled in advanceHelen Torley (PRESIDENT AND CEO) sold ~$83K of Halozyme
Scheduled in advance